Microdosing

microdosing icon GLP-1 MICRODOSE

Invididualized Wellness

microdosing icon GLP-1 MICRODOSE

Clinical Benefits
Beyond Weight Loss 

Microdosing, Made
Affordable

Semaglutide
(GLP-1)
starting at*
*$75/mo
Tirzepatide
(GLP-1 + GIP)

starting at*
*$149/mo
+ $74.99 mo/ Program fee
*RX required after clinical evaluation. This is a compounded medication and is not FDA-approved. Compounded drugs have not undergone FDA review for safety, efficacy, or quality. See Ivím website for full safety information. Results may vary. 

Unlock the Full Potential of GLP-1 Therapy

Recent research has revealed that GLP-1 medications offer significant clinical benefits beyond weight loss from cardiovascular protection to improved metabolic health. Clinical trials are underway to study their impact on conditions like autoimmune and neurocognitive diseases

The GLP-1 Microdosing program uses precision-dosed, lower amounts of GLP-1 medication designed to deliver therapeutic benefits while minimizing or eliminating common side effects. 

Whether you're maintaining your weight loss results after decelerating your GLP-1 dose or seeking the many health benefits of GLP-1 therapy, our individualized microdosing approach puts you in control.

Your Ivím GLP-1 Microdose Patient Journey

Here's what to expect:

Get Started in Minutes

Complete Your Assessment Answer our dynamic questionnaire about your health history, goals, and the specific benefits you're seeking from GLP-1 therapy.

Meet with a Licensed Provider

Video Consultation Meet virtually with an Ivím medical provider who will evaluate your eligibility and discuss your individualized treatment plan.

Receive Your Medication & Labs

Precision Dosing Begins Receive your microdose prescription—starting at just 1/5 of the standard dose—designed for therapeutic benefit with minimal side effects.

Ongoing Care & Support

Ongoing Support & Check-Ins Weekly check-ins allow your provider to monitor your response and adjust your protocol as needed.

Precision Dosing, Personalized for You

Semaglutide
Microdose Protocol
Tirzepatide
Microdose Protocol
Starting dose:
0.05mg weekly 1/5 standard starting dose
0.05mg weekly 1/5 standard starting dose
Gradual titration:
0.1mg
0.15mg
0.2mg
0.1mg
0.15mg
0.2mg
Goal:
Lowest effective dose for your needs
Therapeutic benefit without side 
effects or unwanted weight loss
Need higher doses? Patients can transition to our traditional GLP-1 weight loss program if clinically appropriate.

Understanding GLP-1 Microdosing

Microdosing uses significantly lower doses—starting at 1/5 of the standard amount—to deliver therapeutic benefits while minimizing or eliminating common side effects like nausea and GI discomfort. The goal is optimal health benefits, not aggressive weight loss.

This program is designed for therapeutic benefits beyond weight loss. The goal is weight maintenance or stability—not significant loss.

Patients who meet BMI criteria who are seeking weight maintenance after previous GLP-1 therapy, metabolic health improvement, cardiovascular protection, or other clinical benefits may qualify. A video consultation with an Ivím provider will determine your eligibility.

When prescribed by a licensed provider and monitored appropriately, yes. The lower doses used in this program are specifically designed to reduce the likelihood of side effects while providing therapeutic benefit.

If you and your provider determine that higher doses would be beneficial, you can transition to our traditional GLP-1 program (if you meet the eligibility criteria).

There’s no required timeline at any given dose. Your provider will work with you to find your lowest effective dose and determine the appropriate duration based on your individual goals.